What is the global microbiome therapeutics market in 2026?

The global microbiome therapeutics market is projected to be valued at US$312.5 Million in 2026.

What drives the global microbiome therapeutics market?

The understanding of the human microbiome, high disease prevalence, and increasing investment in microbiome-based therapies are driving market growth.

What is the growth rate for the global microbiome therapeutics market?

The global market is projected to grow at a CAGR of 9.5% between 2026 and 2033.

What are the key microbiome therapeutics market opportunities?

Expanding clinical pipelines, rising adoption in emerging markets, and novel microbiome-based therapeutics development present major growth opportunities.

Who are the key players in the global microbiome therapeutics market?

Major players in the global are Microbiome Therapeutics Innovation Group, SERES Therapeutics, Vedanta Biosciences, Inc., Enterome, Ferring, Evotec AG and others.

Table of Content - Microbiome Therapeutics Market Size, Share, Growth, and Regional Forecast, 2026 to 2033

Executive Summary
1. Global Microbiome Therapeutics Market Snapshot, 2026 and 2033
2. Market Opportunity Assessment, 2026 - 2033, US$ Mn
3. Key Market Trends
4. Future Market Projections
5. Premium Market Insights
6. Industry Developments and Key Market Events
7. PMR Analysis and Recommendations
Market Overview
1. Market Scope and Definition
2. Market Dynamics
  1. Drivers
  2. Restraints
  3. Opportunity
  4. Key Trends
3. Macro-Economic Factors
  1. Global Sectorial Outlook
  2. Global GDP Growth Outlook
4. COVID-19 Impact Analysis
5. Forecast Factors - Relevance and Impact
Value Added Insights
1. Product Adoption Analysis
2. Regulatory Landscape
3. Value Chain Analysis
4. Key Deals and Mergers
5. PESTLE Analysis
6. Porter’s Five Force Analysis
Global Microbiome Therapeutics Market Outlook:
1. Key Highlights
  1. Market Size (US$ Mn) and Y-o-Y Growth
  2. Absolute $ Opportunity
2. Market Size (US$ Mn) Analysis and Forecast
  1. Historical Market Size (US$ Mn) Analysis, 2020-2025
  2. Market Size (US$ Mn) Analysis and Forecast, 2026-2033
3. Global Microbiome Therapeutics Market Outlook: Therapy
  1. Introduction / Key Findings
  2. Historical Market Size (US$ Mn) Analysis, By Therapy, 2020-2025
  3. Market Size (US$ Mn) Analysis and Forecast, By Therapy, 2026-2033
    1. Probiotics
    2. Prebiotics
    3. Postbiotics
    4. Live Biotherapeutic Products (LBP)
    5. Fecal Microbiota Therapy (FMT)
    6. Others
  4. Market Attractiveness Analysis: Therapy
4. Global Microbiome Therapeutics Market Outlook: Application
  1. Introduction / Key Findings
  2. Historical Market Size (US$ Mn) Analysis, By Application, 2020-2025
  3. Market Size (US$ Mn) Analysis and Forecast, By Application, 2026-2033
    1. Gastrointestinal Disorders
    2. Autoimmune Disorders
    3. Metabolic Disorders
    4. Oncology
    5. Neurological Disorders
    6. Others
  4. Market Attractiveness Analysis: Application
5. Global Microbiome Therapeutics Market Outlook: Route of Administration
  1. Introduction / Key Findings
  2. Historical Market Size (US$ Mn) Analysis, By Route of Administration, 2020-2025
  3. Market Size (US$ Mn) Analysis and Forecast, By Route of Administration, 2026-2033
    1. Oral
    2. Rectal
    3. Topical
    4. Others
  4. Market Attractiveness Analysis: Route of Administration
Global Microbiome Therapeutics Market Outlook: Region
1. Key Highlights
2. Historical Market Size (US$ Mn) Analysis, By Region, 2020-2025
3. Market Size (US$ Mn) Analysis and Forecast, By Region, 2026-2033
  1. North America
  2. Europe
  3. East Asia
  4. South Asia and Oceania
  5. Latin America
  6. Middle East & Africa
4. Market Attractiveness Analysis: Region
North America Microbiome Therapeutics Market Outlook:
1. Key Highlights
2. Historical Market Size (US$ Mn) Analysis, By Market, 2020-2025
  1. By Country
  2. By Therapy
  3. By Application
  4. By Route of Administration
3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2026-2033
  1. U.S.
  2. Canada
4. Market Size (US$ Mn) Analysis and Forecast, By Therapy, 2026-2033
  1. Probiotics
  2. Prebiotics
  3. Postbiotics
  4. Live Biotherapeutic Products (LBP)
  5. Fecal Microbiota Therapy (FMT)
  6. Others
5. Market Size (US$ Mn) Analysis and Forecast, By Application, 2026-2033
  1. Gastrointestinal Disorders
  2. Autoimmune Disorders
  3. Metabolic Disorders
  4. Oncology
  5. Neurological Disorders
  6. Others
6. Market Size (US$ Mn) Analysis and Forecast, By Route of Administration, 2026-2033
  1. Oral
  2. Rectal
  3. Topical
  4. Others
7. Market Attractiveness Analysis
Europe Microbiome Therapeutics Market Outlook:
1. Key Highlights
2. Historical Market Size (US$ Mn) Analysis, By Market, 2020-2025
  1. By Country
  2. By Therapy
  3. By Application
  4. By Route of Administration
3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2026-2033
  1. Germany
  2. France
  3. U.K.
  4. Italy
  5. Spain
  6. Russia
  7. Türkiye
  8. Rest of Europe
4. Market Size (US$ Mn) Analysis and Forecast, By Therapy, 2026-2033
  1. Probiotics
  2. Prebiotics
  3. Postbiotics
  4. Live Biotherapeutic Products (LBP)
  5. Fecal Microbiota Therapy (FMT)
  6. Others
5. Market Size (US$ Mn) Analysis and Forecast, By Application, 2026-2033
  1. Gastrointestinal Disorders
  2. Autoimmune Disorders
  3. Metabolic Disorders
  4. Oncology
  5. Neurological Disorders
  6. Others
6. Market Size (US$ Mn) Analysis and Forecast, By Route of Administration, 2026-2033
  1. Oral
  2. Rectal
  3. Topical
  4. Others
7. Market Attractiveness Analysis
East Asia Microbiome Therapeutics Market Outlook:
1. Key Highlights
2. Historical Market Size (US$ Mn) Analysis, By Market, 2020-2025
  1. By Country
  2. By Therapy
  3. By Application
  4. By Route of Administration
3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2026-2033
  1. China
  2. Japan
  3. South Korea
4. Market Size (US$ Mn) Analysis and Forecast, By Therapy, 2026-2033
  1. Probiotics
  2. Prebiotics
  3. Postbiotics
  4. Live Biotherapeutic Products (LBP)
  5. Fecal Microbiota Therapy (FMT)
  6. Others
5. Market Size (US$ Mn) Analysis and Forecast, By Application, 2026-2033
  1. Gastrointestinal Disorders
  2. Autoimmune Disorders
  3. Metabolic Disorders
  4. Oncology
  5. Neurological Disorders
  6. Others
6. Market Size (US$ Mn) Analysis and Forecast, By Route of Administration, 2026-2033
  1. Oral
  2. Rectal
  3. Topical
  4. Others
7. Market Attractiveness Analysis
South Asia & Oceania Microbiome Therapeutics Market Outlook:
1. Key Highlights
2. Historical Market Size (US$ Mn) Analysis, By Market, 2020-2025
  1. By Country
  2. By Therapy
  3. By Application
  4. By Route of Administration
3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2026-2033
  1. India
  2. Southeast Asia
  3. ANZ
  4. Rest of South Asia & Oceania
4. Market Size (US$ Mn) Analysis and Forecast, By Therapy, 2026-2033
  1. Probiotics
  2. Prebiotics
  3. Postbiotics
  4. Live Biotherapeutic Products (LBP)
  5. Fecal Microbiota Therapy (FMT)
  6. Others
5. Market Size (US$ Mn) Analysis and Forecast, By Application, 2026-2033
  1. Gastrointestinal Disorders
  2. Autoimmune Disorders
  3. Metabolic Disorders
  4. Oncology
  5. Neurological Disorders
  6. Others
6. Market Size (US$ Mn) Analysis and Forecast, By Route of Administration, 2026-2033
  1. Oral
  2. Rectal
  3. Topical
  4. Others
7. Market Attractiveness Analysis
Latin America Microbiome Therapeutics Market Outlook:
1. Key Highlights
2. Historical Market Size (US$ Mn) Analysis, By Market, 2020-2025
  1. By Country
  2. By Therapy
  3. By Application
  4. By Route of Administration
3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2026-2033
  1. Brazil
  2. Mexico
  3. Rest of Latin America
4. Market Size (US$ Mn) Analysis and Forecast, By Therapy, 2026-2033
  1. Probiotics
  2. Prebiotics
  3. Postbiotics
  4. Live Biotherapeutic Products (LBP)
  5. Fecal Microbiota Therapy (FMT)
  6. Others
5. Market Size (US$ Mn) Analysis and Forecast, By Application, 2026-2033
  1. Gastrointestinal Disorders
  2. Autoimmune Disorders
  3. Metabolic Disorders
  4. Oncology
  5. Neurological Disorders
  6. Others
6. Market Size (US$ Mn) Analysis and Forecast, By Route of Administration, 2026-2033
  1. Oral
  2. Rectal
  3. Topical
  4. Others
7. Market Attractiveness Analysis
Middle East & Africa Microbiome Therapeutics Market Outlook:
1. Key Highlights
2. Historical Market Size (US$ Mn) Analysis, By Market, 2020-2025
  1. By Country
  2. By Therapy
  3. By Application
  4. By Route of Administration
3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2026-2033
  1. GCC Countries
  2. Egypt
  3. South Africa
  4. Northern Africa
  5. Rest of Middle East & Africa
4. Market Size (US$ Mn) Analysis and Forecast, By Therapy, 2026-2033
  1. Probiotics
  2. Prebiotics
  3. Postbiotics
  4. Live Biotherapeutic Products (LBP)
  5. Fecal Microbiota Therapy (FMT)
  6. Others
5. Market Size (US$ Mn) Analysis and Forecast, By Application, 2026-2033
  1. Gastrointestinal Disorders
  2. Autoimmune Disorders
  3. Metabolic Disorders
  4. Oncology
  5. Neurological Disorders
  6. Others
6. Market Size (US$ Mn) Analysis and Forecast, By Route of Administration, 2026-2033
  1. Oral
  2. Rectal
  3. Topical
  4. Others
7. Market Attractiveness Analysis
Competition Landscape
1. Market Share Analysis, 2025
2. Market Structure
  1. Competition Intensity Mapping By Market
  2. Competition Dashboard
3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
  1. Microbiome Therapeutics Innovation Group
    1. Overview
    2. Segments and Product
    3. Key Financials
    4. Market Developments
    5. Market Strategy
  2. SERES Therapeutics
  3. Vedanta Biosciences, Inc.
  4. Enterome
  5. Ferring
  6. Evotec AG
  7. Synlogic
  8. Osel Inc.
  9. OxThera
  10. AOBiome
  11. Immuron Limted
  12. MRM Health NV
  13. Microbiotica
  14. BiomeBank
  15. Finch Therapeutics Group, Inc.
  16. NuBiyota
  17. MaaT Pharma
  18. LNC Therapeutics
Appendix
1. Research Methodology
2. Research Assumptions
3. Acronyms and Abbreviations

Microbiome Therapeutics Market Size, Share, Growth, and Regional Forecast, 2026 to 2033

Microbiome Therapeutics Market by Therapy (Probiotics, Prebiotics, Postbiotics, Live Biotherapeutic Products (LBP), Fecal Microbiota Therapy (FMT), Others), Application, Route of Administration, and Regional Analysis from 2026 to 2033

Quick Links

Our Partners

Secure Payments Through